Clinical Trial Update: Mechanisms of Anti-VEGF Induced Hypertension

View source ↗

Summary

This is a completed clinical trial update examining the mechanisms of hypertension induced by anti-VEGF therapy in renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Arduino Mangoni | Conditions: Renal Cancer | Status: COMPLETED